Sustained deep clinical and itch responses with novel IL-13 inhibitor Presented ByProf. Eric Simpson, Oregon Health & Science University, USA TrialPhase 3, ADvocate; ADvantage ConferenceEADV 2023 TypePeer-reviewed article 28 November 2023 13:13